Metropolitan Life Insurance CO Aura Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$8.51 - $13.33 $3,574 - $5,598	420 Added 37.1%	1,552 $19,000
Q1 2023 May 15, 2023	SELL	$8.88 - $12.11 $1,314 - $1,792	-148 Reduced 11.56%	1,132 $10,000
Q4 2022 Jun 14, 2023	BUY	$9.86 - $14.59 $1,459 - $2,159	148 Added 13.07%	1,280 $13.4 Million
Q3 2022 Jun 14, 2023	BUY	$13.1 - $20.34 $1,938 - $3,010	148 Added 13.07%	1,280 $23.2 Million
Q2 2022 Jun 20, 2023	BUY	$12.37 - $21.86 $1,830 - $3,235	148 Added 13.07%	1,280 $18,000
Q2 2022 Aug 11, 2022	BUY	$12.37 - $21.86 $15,833 - $27,980	1,280 New	1,280 $18,000

37.6M

122K

38.5K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $268M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.